Lethal Injections on Death Watch

March 2011
Pharmaceutical Representative;Mar2011, Vol. 41 Issue 3, p8
The article discusses issues concerning the shortage of sodium thiopental, a drug which is used in lethal injections, in the U.S. as well as a lawsuit filed against the Food and Drug Administration (FDA) due to its failure to inspect shipments of the drug.


Related Articles

  • Court upholds the FDA on dosage-form classes. Dickinson, James G. // Medical Marketing & Media;Jun98, Vol. 33 Issue 6, p28 

    Presents information on a law suit brought by the Pfizer company, against the United States Food and Drug Administration, in relation to the meaning of `dosage form,' in the Abbreviated New Drug Applications. Argument brought by the plaintiff; Ruling of the court.

  • STRUCK DOWN. Conlan, Michael F. // Drug Topics;3/5/2001, Vol. 145 Issue 5, p66 

    Deals with the decision made by the 9th United States (U.S.) Circuit Court of Appeals in San Francisco, California regarding the role of the U.S. Food and Drug Administration on compounding drugs. Response of different organizations in the pharmaceutical industry to the decision; Information on...

  • FDA tightens control over India’s API manufacturers. RAMESH, DEEPTI // Chemical Week;6/23/2014, Vol. 176 Issue 17, p31 

    The article examines regulation by the U.S. Food & Drug Administration (FDA) of active pharmaceutical ingredient (API) manufacturing plants located in India. Warning letters sent by the FDA to pharmaceutical industry firms including Apotex, Canton Laboratories and Fresenius following inspections...

  • Allergan Files 'Speech' Suit.  // BioWorld Today;10/5/2009, Vol. 20 Issue 191, p3 

    The article reports that a lawsuit has been filed by Allergan Inc. against the U.S. Food and Drug Administration (FDA) alleging that the law prohibiting drugmakers from communicating off-label uses is in violation of the First Amendment freedom of speech rights. Allergan officials claimed that...

  • Public Citizen sues FDA over MedGuide regs.  // Medical Marketing & Media;Apr2003, Vol. 38 Issue 4, p19 

    Reports on a lawsuit filed by an organization called Public Citizen against the U.S. Food and Drug Administration (FDA) in February 2003 for failing to solicit public comments on its 1995 medication guide regulation. Allegation that patients have not been receiving adequate drug safety...

  • Court orders release of FDA drug files. Dickinson, James G. // Medical Marketing & Media;May98, Vol. 33 Issue 5, p40 

    Focuses on a ruling by federal judge Royce Lamberth on a case between private citizens and the United States Food and Drug Administration (FDA) on animal toxicity of products used by humans. Other information on Freedom of Information lawsuit; Reference to Schering Corporation.

  • Generic drug firms sue FDA.  // Medical Marketing & Media;Apr99, Vol. 34 Issue 4, p28 

    Reports on the lawsuit filed by the generic drug industry against the United States Food and Drug Administration over the extension of market exclusivity of drugs when companies agree to perform requested pediatric studies.

  • Groups sue FDA over livestock regulations. Pecquet, Julian // Hill;5/26/2011, Vol. 18 Issue 73, p14 

    The article reports on the legal action taken by a coalition of consumer groups against the U.S. Food and Drug Administration (FDA) over the use of antibiotics in animal agriculture.

  • Steep increase in lawsuits against FDA. Dickinson, James G. // Medical Marketing & Media;Nov97, Vol. 32 Issue 11, p32 

    Focuses on the significant increase in the number of federal court cases filed against the US Food and Drug Administration (FDA) as of August 19, 1997.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics